PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function


Basic Trial Information

Protocol Phase:Phase I
Study Category:Biomarker/Laboratory analysis
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary IDCTKI258A2124
Other IDNCT01443481
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: